Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Where the cash went Twelve months to Sep 30, 2026
Free cash flow was −$236.9M: capital expenditures were more than operating cash flow. Cash fell by $164.4M. Lines the picture does not name came to +$332.0M. What is a cash flow statement?
- Free cash flow
- −$236.9M −59.1% of operating cash flow
- Returned to shareholders
- $302.8M
- Debt, net
- −$157.3M repaid
- Change in cash
- −$164.4M over the period
| Operating cash flow | 400.6 |
|---|---|
| Capital expenditures | −637.5 |
| Free cash flow | −236.9 |
| Into investments, net | −2.6 |
| Dividends | −302.8 |
| Shares issued, net | +203.1 |
| Debt repaid, net | −157.3 |
| Other | +332.0 |
| Change in cash | −164.4 |
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Operating cash flow | $349M | $367M | $372M | $401M |
| Capex | −$406M | −$498M | −$649M | −$637M |
| Free cash flow | −$57M | −$131M | −$277M | −$237M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more TTM periods Free account |
155.51 | 156.02 | 65.23 | 71.27 |
Depreciation & Amortization |
187.00 | 196.63 | 209.43 | 225.69 | |
Non Cash Items (Other) |
15.96 | 15.81 | 105.62 | 105.19 | |
Accounts Receivable Change |
(11.45) | (10.16) | (16.50) | (18.77) | |
Change in payables and accrued liability |
1.60 | 8.42 | 7.81 | 17.20 | |
Operating Cash Flow |
348.61 | 366.71 | 371.57 | 400.58 | |
Capital expenditures |
(405.82) | (498.13) | (648.80) | (637.47) | |
Long-Term Investments Change (Net) |
(1.25) | (0.23) | (0.67) | (2.61) | |
Other investing activities |
29.11 | 31.75 | 314.50 | 333.11 | |
Investing cash flow |
(377.96) | (466.61) | (334.97) | (306.98) | |
Repayment/Issuance of Debt (Net) |
107.72 | 269.38 | 153.34 | (157.33) | |
Equity Repurchase (Common, Net) |
227.78 | 224.93 | 251.28 | 203.12 | |
Dividends Paid (Total) |
(289.50) | (293.78) | (298.06) | (302.76) | |
Other financial activities |
(5.24) | (6.43) | (6.55) | (1.44) | |
Financing cash flow |
40.76 | 194.10 | 100.01 | (258.41) | |
Exchange Rate Adjustment |
0.39 | 0.35 | 0.08 | 0.38 | |
Change in Cash |
11.80 | 94.55 | 136.69 | (164.44) | |
Beginning Cash |
66.34 | 78.14 | 78.14 | 78.14 | |
Ending Cash |
78.14 | 172.69 | 214.83 | (86.30) | |
Stock Based Compensation |
11.36 | 11.75 | 13.13 | 14.18 | |
Dividends Paid (Common) |
(289.50) | (293.78) | (298.06) | (302.76) | |
Assets Liabilities Change (Total) |
(9.85) | (1.75) | (8.70) | (1.57) | |
Investments Change (Net) |
(1.25) | (0.23) | (0.67) | (2.61) | |
Issuance/Purchase of Shares |
227.78 | 224.93 | 251.28 | 203.12 |